Key messages
inflammation
ADVERSE EVENTS, INFLAMMATION

Ghanaian and Malawian women assigned to receive iron and folic acid (pregnancy only) or multiple micronutrients (pregnancy and lactation) or small‐quantity lipid‐based nutrient supplements (SQ‐LNSs) (pregnancy and lactation) generally did not differ in morbidity outcomes during the second and third trimesters of pregnancy and 0–3 and 3–6 months lactation.The lack of group differences in most of the morbidity outcomes corroborates previous results of no significant group differences in the percentage of women who experienced severe adverse events or mean concentrations of two biomarkers of inflammation (C‐reactive protein and alpha‐1 glycoprotein) or percentage of women with elevated concentrations of the biomarkers.Overall, there was no consistent evidence that SQ‐LNS or multiple micronutrients increased or decreased maternal morbidity during pregnancy or lactation, compared to iron and folic acid.
